Logo image
Prophylactic Pancreatectomies Carry Prohibitive Mortality at Low-Volume Centers: A California Cancer Registry Study
Journal article   Peer reviewed

Prophylactic Pancreatectomies Carry Prohibitive Mortality at Low-Volume Centers: A California Cancer Registry Study

Ann Falor Callahan, Philip H. G. Ituarte, Leanne Goldstein, Susanne G. Warner, Yanghee Woo, Gagandeep Singh, Yuman Fong and Laleh G. Melstrom
World Journal of Surgery, Vol.43(9)
2019

Abstract

Adult Aged California Female Hospital Mortality Hospitals, High-Volume Hospitals, Low-Volume Humans Male Middle Aged Pancreatectomy Pancreatic Cyst Pancreatic Neoplasms Registries Retrospective Studies adult aged California epidemiology female high volume hospital hospital mortality human low volume hospital male middle aged pancreas cyst pancreas tumor pancreatectomy procedures register retrospective study
Background: Pancreatectomy for malignancy is associated with improved outcomes when performed at high-volume centers. The goal of this study was to assess pancreatectomy outcomes for premalignant cystic lesions as a function of hospital volume. Methods: The Healthcare Cost and Utilization Project (HCUP) was queried for all pancreatectomies performed in California from 2003 to 2011. Cases were stratified, separating benign versus malignant disease. Hospitals were categorized as low-volume (≤25 pancreatectomies/year; LV) or high-volume (>25; HV) centers. Perioperative morbidity, mortality, and length of stay were compared in HV vs. LV centers. Results: There were 7554 pancreatectomies performed in 201 hospitals during the study period, where 5652 (75%) procedures were performed for malignancy, 338 (4%) for chronic pancreatitis, and 1564 (21%) for benign/premalignant cysts. The majority of pancreatectomies for cystic disease were performed at LV centers (65%). There were no significant differences in length of stay (7 vs. 8 days; p = 0.6) or 90-day readmission rates (12.8% vs. 12.9%; p = 1.0) in HV versus LV centers. However, there were higher surgical (46.2% LV vs. 41.1% HV, p = 0.05) and medical (13.3% LV vs. 9.2% HV; p = 0.017) complications at LV centers. Most importantly, there was a fourfold higher in-hospital mortality at LV centers (2.36% vs. 0.55%; p = 0.007). Conclusion: Pancreatic resection for benign lesions at HV hospitals is associated with significantly lower morbidity and mortality, suggesting that when feasible, patients should seek care at high-volume centers for these semi-elective surgeries. © 2019, Société Internationale de Chirurgie.

Metrics

4 Record Views

Details

Logo image